The Merlin team had a very successful plenary in Rotterdam on 10 and 11 May. Updates were presented on each WP. MSC production and preparation for the upcoming trial were naturally a key focus at this stage of the project. Publications and plans for future work were also discussed. Many thanks to EMC for hosting and to all the partners for their input into a very productive and enjoyable meeting!
- RT @AutoImmuneLiver: Stay conmected with patient support groups @PSCSupportUK @PSCPartners to keep up with progress. Cure is a challenge bu… Time ago 72 Days via Twitter Web Client
- RT @nephstrom: JUST OUT! A new #OpenAccess @nephstrom publication in @FrontImmunol from our partners at @Istituto di Ricerche Farmacologich… Time ago 72 Days via Twitter Web Client
- RT @EUPHORIAH2020: Noninvasive modalities MRI, PET identify intestinal inflammation, longitudinally monitor disease status or detect change… Time ago 82 Days via Twitter for iPhone
Follow @fp7merlin on twitter.
This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 602363. The material presented and views expressed here are the responsibility of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.